Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI
| Current Price | ₹637.20 |
|---|---|
| Market Cap | ₹10,076 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 36.4 |
| Return on Equity | 9.18% |
| 52-Week Range | ₹537.30 – ₹851.80 |
| Beta (1Y) | 0.41 |
| Dividend Yield | 0.78% |
Jubilant Ingrevia Ltd is trading at ₹637.20, with a market capitalisation of ₹10,076 Cr.
Jubilant Ingrevia Ltd operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Jubilant Ingrevia Ltd has a P/E of 36.4 and a return on equity of 9.18%.